The Patented Medicines Price Review Board Proposed Guidelines & the Threat to Treatments for Lung Disease Patients
Looming national changes to drug pricing guidelines may harm Canadian lung disease patient’s access to new and innovative treatments.
Looming national changes to drug pricing guidelines may harm Canadian lung disease patient’s access to new and innovative treatments.
This opportunity is ideal for people who do not have a support group in their community or who may be unable to attend an in-person meeting.
Two million of us live with it – and we estimate that it’s affecting one million more Canadians without their knowledge. What makes COPD the most common chronic illness that nobody’s talking about?
Prior to 2020, the Lung Health Foundation operated as the Ontario Lung Association. Enjoy this content from our archives. The flu vaccine is typically available in mid-October, but a rare month-long delay in the World …